Figure 2From: Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany Kaplan-Meier curves showing the cumulative probabilities of continuation of therapy (persistence) in patients treated at index prescription with Gb at 240 mg dosage strength, 120 mg dosage strength, or less than 120 mg dosage strength. Back to article page